Tag Archives: health

Global Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Hepatitis C Virus Testing Market
Hepatitis C is a liver sickness which is transmitted by the contact with the blood of a contaminated individual. Hepatitis C indicate huge hereditary variety in populace around the world, because of high rate of viral RNA transformations. HCV has six variations (HCV genotypes 1, 2, 3, 4, 5, and 6), and 15 subtypes are recorded which differ in the rate of commonness around the world. Diverse sorts of gadgets are utilized for the determination of hepatitis C, including HCV viral load test, HCV neutralizer test, HCV genotype test and liver biopsy. Economical, fast, vigorous, and touchy logical gadgets are basic for viable, precise determination and observing of sickness treatment.
Increase in hepatitis C virus testing Market is mainly attributed to high incidence of chronic infection with hepatitis C virus. Furthermore, unhygienic blood donation practices are the considerable cause of spread of hepatitis C virus. Hepatitis C screening test is compulsory before the organ donation, increase in organ donation globally expected to boost the testing market growth. The increase in healthcare expenditure, changing lifestyle and increase in government initiatives are some of the key factors driving the growth of global hepatitis C virus antiviral Testing Market. In addition, growing healthcare awareness about the hepatitis C virus is also fueling the growth of global hepatitis C virus testing market. However, stringent regulation for approval of hepatitis C testing is the major factor expected to hamper the hepatitis C virus testing market.
A sample of this report is available upon request @
Globally, hepatitis C virus testing market is segmented based on technique, test type, end-user.
Based on technique, hepatitis C virus testing market is segmented as:
• Polymerase Chain Reaction Tests
• Immunoassays
• Others
Based on test, hepatitis C virus testing market is segmented as:
• Hepatitis C antibody
• Hepatitis C RNA quantitative test
• Hepatitis C RNA qualitative test
• Hepatitis C RIBA
• Hepatitis C genotype
• Viral load
Based on the end-user, hepatitis C virus testing market is segmented as:
• Hospitals
• Diagnostic Centres
• Blood Donation centers
To view TOC of this report is available upon request @
When compared to hepatitis A and hepatitis B Prevalence of hepatitis C is low. According to Institute of Liver and Biliary Sciences India (ILBS) around 3% of population globally, infected with hepatitis C virus, therefore minimum R&D investments by market players to develop new and effective hepatitis C virus tests. Among the all tests, HCV antibody testing is expected to occupy more share because antibody testing is the primarily used test for HCV testing. In end user segment, diagnostic centers is expected to have major market share in HCV testing market. Application of new electrochemical immune sensor and genosensor technologies in HPV testing are expected to change conventional HPV testing practices.
Need more information about this report @
Geographically, hepatitis C virus testing Market is divided into Asia-Pacific, Latin America, North America, Europe and The Middle East and Africa. Europe hepatitis C market is expected to grow at significant rates owing to incidence of hepatitis C virus diseases. According to WHO European region have 1.5% and Eastern Mediterranean has 2.3% prevalence of HCV diseases that shows significant variations in genes in population globally due to high rates of mutation of viral RNA. Asia Pacific is expected to be having lucrative market growth over the forecasting period owing to disease prevalence rates.
Some of the players in global hepatitis C virus testing Market include Abbott Laboratories (U.S.), Bio Rad Laboratories Inc. (U.S.), Qiagen (Germany), Bayer AG (Switzerland), OraSure Technologies (U.S.), Siemens Healthcare GmbH (Germany), BioGenex (U.S.), H. Hoffman-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostic Inc. (U.S.), among others.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

Global Hepatitis C Treatment Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Hepatitis C is an irresistible infection caused by Hepatitis C infection (HCV) and influences essentially the liver. Hepatitis C is normally caused by blood to blood contacts, for example, intravenous medication utilize, unsterilized hardware, blood transfusions, and ***. Hepatitis C may likewise cause from mother to embryo amid birth. Individuals with liquor abuse and HIV disease of all ages assemble are at expanded hazard. As of now, there is no immunization accessible to treat hepatitis C conditions. In any case, different medications, for example, protease inhibitors, HCV polymerase inhibitors, and HCV NS5A inhibitors are normally used to treat Hepatitis C. Beginning time of contamination regularly has no side effects. The basic phase of contamination may show indications, for example, fever, dull pee, stomach agony, and yellow-tinged skin event. The seriousness in hepatitis C may prompt liver cirrhosis, liver disease, liver disappointment, and now and again likewise causes the widened veins in the throat and stomach. Hepatitis C can be averted by utilizing disinfected hardware, screening of blood givers, keeping away from numerous sexual accomplices, and abstaining from sharing of infusions and razors.
The global market for Hepatitis C treatment market is expected to grow at a significant CAGR due to increase in the prevalence of Hepatitis C infection. Rising awareness regarding Hepatitis C treatment, increase in healthcare expenditure, and government initiatives and various NGO’s creating awareness regarding the Hepatitis C treatment is expected to fuel the market growth over the forecast period. In addition, rise in the funding in research and development activities for Hepatitis C treatment and strong pipeline products might boost the global Hepatitis C treatment market over the forecast period. However, lack of antibiotics in the market, high cost of medications, and lack of hepatitis C infection awareness in poor countries might hamper the growth of global Hepatitis C treatment market over the forecast period.
A sample of this report is available upon request @
Hepatitis C treatment market segmented on the basis of drug class, route of administration, and distribution channel
Based on drug class, the hepatitis C treatment market has been segmented into the following:
• Polymerase Inhibitors
• NS5A Inhibitors
• Interferons
• HCV protease inhibitors
• Combination Therapy
Based on route of administration, the hepatitis C treatment market has been segmented into the following:
• Oral
• Parenteral
Based on distribution channel, the hepatitis C treatment market has been segmented into the following:
• Retail Pharmacies
• Hospital Pharmacies
• Others
To view TOC of this report is available upon request @
Increase in prevalence of hepatitis C infection and liver cirrhosis expected to fuel the growth of Hepatitis C treatment market. According to the World Health Organization (WHO), globally there are 80 Mn people suffers from chronic hepatitis C virus, in that approximately 700,000 will die each year as a result of the infection. Acquisitions and mergers, collaborations, launching of new products, increase in research and development activities, and approvals for new products from various drug regulatory bodies such as U.S. Food and Drug Administration are some strategies followed by various companies to increase their market share in global hepatitis C treatment market. For instance, in July 2011, Merck MSD, inked an agreement with Roche for the marketing approvals of Victreli (Boceprevir) triple combination therapy with peginterferon alfa and ribavirin (peg/riba). In addition, in August 2011, Vertex Pharmaceuticals Incorporated announced that Health Canada approved its Incivektm (Telaprevir) tablets for people with genotype 1 chronic hepatitis C with compensated liver disease. In January 2014, European Commission (EC) granted marketing authorization for Gilead’s Sovaldi (Sofosbuvir) to treat chronic hepatitis C infection.
Need more information about this report @
Geographically, the hepatitis C treatment market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global hepatitis C treatment market followed by Europe and Asia-Pacific. Increase in prevalence of hepatitis C infection (according to Centres for Disease Prevention and Control (CDC), approximately 2.7-3.9 Mn people in the United States are chronically infected with hepatitis C Virus), rise in the awareness among the key stakeholders towards the use of novel products and technologies to treat the hepatitis C, and increase in research and development activities are the key factors bolster the hepatitis C treatment market in North America region. Europe holds a key share in hepatitis C treatment market owing to increase in prevalence of Hepatitis C infection (according to European centre for Disease Prevention and Control approximately 5.9 Mn people are suffering from HCV infection), rise in the geriatric population, change in the lifestyle, people involving in the unprotected sexual intercourse, and increase in the research and development activities might boost the hepatitis C treatment market in Europe region. Asia-Pacific hepatitis C treatment market growth is attributed to increase in the prevalence of hepatitis C infection, rise in the population in Asia-Pacific region, and increase in the healthcare infrastructure. The Middle East & Africa region has high prevalence of HCV infection majorly in Egypt that is approximately 8434 prevalent cases per 100,000 people.
Some of the players in Hepatitis C treatment market are GlaxoSmithKline, plc. (U.K.), Bristol-Myers Squibb (U.S), F. Hoffmann- La Roche Ltd. (Switzerland), Merck & Co, Inc. (U.S),  Johnson & Johnson Services, Inc. (U.S.), Gilead Sciences (U.S.), AbbVie Inc. (U.S.), Vertex Pharmaceuticals Inc. (U.S.), and Kadmon Holdings, Inc. (U.S.) to name a few.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
I

Global Hepatitis B Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Hepatitis B Virus Testing Market
Hepatitis B is a liver sickness caused by the Hepatitis B infection (HBV). Hepatitis B viral contamination extents can shape mellow disease which most recent couple of weeks and an unending contamination that may prompt liver issue and even demise. Hepatitis B is one of the worldwide medical issue. Hepatitis B can cause incessant disease and puts individuals at high danger of death from cirrhosis and liver tumor. The infection is transmitted through contact with the blood or other body liquids of a tainted individual. As per World Health Organization, 257 Mn individuals are living with hepatitis B infection disease worldwide and in 2015, 887 000 hepatitis B came about passings.
Increase in liver cancer cases, growing aging population, healthcare spending and urbanization. Leading to better monitoring and screening procedures. In addition, government initiatives in growing awareness in public, increase in R&D spending by companies and growing demand for bio marker tests due to its accuracy expected to boost the hepatitis B virus testing market during the forecast period. However, factors such as lack of awareness in developing countries, stringent regulatory rules, rigid competition and high cost of testing are expected to hamper the hepatitis B virus testing market over the forecast period.
A sample of this report is available upon request @
The global hepatitis B testing market is classified on the basis of test type, technique end use, and geography.
Based on test type, the global hepatitis B diagnostic test market is segmented into the following:
• Hepatitis B surface antigen test (HBsAg)
• Anti-hepatitis B surface antibody test
• Hepatitis B core antigen test (HBcAb)
• Anti-hepatitis B core antibody test
• HBV DNA test
• Others
Based on techniques, the global hepatitis B diagnostic test market is segmented into the following:
• PCR
• Radioimmunoassay (RIA)
• Enzyme-linked immunosorbent assay (ELISA)
• Others
Based on end-user type, the global hepatitis B diagnostic test market is segmented into the following:
• Hospitals
• Diagnostic centers
• Clinics
To view TOC of this report is available upon request @
Currently, more than 13 immunoassays are available to diagnose hepatitis B virus at an early stage. They can also be used to distinguish acute and chronic hepatitis B infections. Many governments in the European countries and the US made it mandatory for the people to go through the screening and proper monitoring since hepatitis B takes the time to develop and is not easily recognizable. There are some curative therapies available but they are not very efficient. It is expected that many innovative therapies which have shown positive results in trials will occupy the market in the coming years. Many companies have products related to hepatitis B in their pipeline. Vendors are developing devices and systems that help integrate laboratory applications. For instance, in 2010 the COBAS 6000 modular platform by Roche Diagnostics offers optimum efficiency and consolidation in medium- and high-volume laboratories.
Need more information about this report @
Geographically, hepatitis B testing market has been segmented into North America, Europe, Latin America, Asia-Pacific, and The Middle East & Africa. North America dominated the hepatitis B therapeutics market owing to the high awareness levels, availability of improved infrastructure, and favourable government initiatives relating to the promotion of hepatitis B therapeutics. Europe is the second largest market for hepatitis B therapeutics driven by rising geriatric population, high rates of chronic infections in Central and Eastern Europe e European Centre for Disease Prevention and Control (ECDC) estimates an overall hepatitis B incidence of 1.49 per 100 000, prevalence of hepatitis B is the highest in Middle East & Africa where adult population is chronically infected. According to World Health Organization (WHO), 2% to 5% of population is affected with hepatitis B virus in Asia Pacific region. And most people die with liver diseases.
Some of the players hepatitis B testing market are Onsite Lab Holding AG (MedMira Inc.) (Switzerland), F. Hoffmann-La Roche (Switzerland), Abbott Laboratories (USA), Siemens AG (Siemens Healthcare GmbH) (Germany), Fisher Bioblock Bolding (Thermo Fisher Scientific) (France), Innovita biological technology Co. Ltd. (China), General Biologicals Corporation (Taiwan), Nantong Diagnos Biotechnology Co. Ltd. (China), Blue Cross Bio-Medical (China) Co. Ltd., BioGenex (U.S.), and Abnova Corporation (U.S.), among others.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
I

Global Biopharmaceutical Contract Manufacturing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Biopharmaceutical contract fabricating market is chiefly determined by increment in speculation of the pharma and biotechnological organizations to create and popularize the biotechnological items. What’s more, high income age of blockbuster organic medications, for example, humira, rituxan, lantus, avastin, herceptin and remicade are picking up footing from numerous biologics producers. Progressions in the biotechnology, for example, recombinant DNA advances and focused on tranquilize treatments are relied upon to reinforce the biopharmaceutical contract producing market over the gauge time frame. Besides, to take care of demand for organic items, organizations are outsourcing the biopharmaceutical assembling to different contract producing organizations. In any case, high cost related with fabricate and stringent administrative necessities are required to hamper the development of biopharmaceutical contract producing market.

Global Artificial Tooth Root Market Outlook & Deep Study of Top Consumers, Players and Strategies

Market Research HUB

Albany, New York, Nov 13, 2017:    Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Artificial Tooth Root Market” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions.

Request For Free Sample – https://www.marketresearchhub.com/enquiry.php?type=S&repid=1367829

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Artificial Tooth Root in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan

Global Cryotherapy Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Global Cryotherapy Devices Market

Cryotherapy is also called as cryosurgery. Cryotherapy is use of freezing agents such as carbon dioxide, liquid nitrogen, freon to freeze and treat the lesions such as tans (skin), moles and prostate cancer. In cryotherapy, a probe is inserted into the tissue next to the affected nerve. The temperature of the probe decreases to very cold temperatures and effectively freezes the nerve. The freezing inactivates the nerve, as a result, painful nerve irritation is relieved. Cryotherapy is a relatively safe and effective means of treating localized nerve irritation.

Global Crohn’s Disease Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Global Crohn’s Disease Treatment Market

Crohn’s disease belongs to a condition called inflammatory bowel disease (IBD) that causes inflammation and damage to the digestive tract. Crohn’s disease usually affects at the end of small intestine and beginning of colon, but inflammation may occur anywhere along the digestive tract. Crohn’s disease may be hereditary or develop due to the malfunctioning of the immune system. Currently there is no cure for crohn’s disease. However, there are many treatments to manage disease symptoms. Inflammation, ulcers, bowel obstruction, malnutrition, colon cancer, and anal fissures are some of the complications associated with the disease. Surgery and drug therapy are some of the treatment options available to treat Crohn’s disease. Some of the anti-inflammatory drugs used to treat crohn’s disease include, corticosteroids and oral 5-aminosalicylates.

Global Research Report Examine Animal Health Biotechnology Market, Industry Analysis,Growth & Forecast 2024

Biotechnology utilized in animal healthcare dates back to 19th century when the first vaccines were prepared for its use in animals. Considerable progress in the animal health biotechnology took place recently when biotechnology applications were utilized in both detecting and treating various infectious and parasitic diseases of animals. This has led to the development of a range of applications and procedures, which will benefit both domestic and wild animals. This will also improve the health of various companion animals, help in improving sporting animals’ performance and the productivity of farm animals. However, the globalized trade in live animals, animal products, and their feeds is leading to a continuously increasing threat of infectious diseases worldwide. Thus, to prevent the spread of infectious diseases, the World Organization for Animal Health (OIE) emphasizes the importance of very rapid, accurate, highly specific and sensitive detection and identification of infectious agents; and prompt and effective control of those diseases.

Global Behavioral/Mental Health Software Market Analysis, Trends, Price, Revenue & Forecast Until 2022

Albany, New York, Nov 08, 2017: The market for Behavioral/Mental Health Software is growing with the expansion of the healthcare Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Behavioral/Mental Health Software Market Report 2017” which offer details about the current trends as well as scope for the Behavioral/Mental Health Software Industry in the coming future. This research study also covers information about the production and market share based on different active regions. Furthermore, an anticipated growth at a double-digit CAGR for the concerned sector is highlighted in the report which indicates a prosperous future.

Designed by CyFocus.com
Powered by CyFocus.net